Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II-III esophageal squamous cell carcinoma

OBJECTIVE: Definitive chemoradiotherapy (CRT) remains the most commonly used treatment for locally advanced esophageal squamous cell carcinoma (SCC), owing to perceptions that esophagectomy offers an unclear survival advantage. We compare recurrence, overall survival (OS), and disease-free survival...

詳細記述

保存先:
書誌詳細
出版年:J Thorac Cardiovasc Surg
主要な著者: Barbetta, Arianna, Hsu, Meier, Tan, Kay See, Stefanova, Dessislava, Herman, Koby, Adusumilli, Prasad S., Bains, Manjit S., Bott, Matthew J., Isbell, James M., Janjigian, Yelena Y., Ku, Geoffrey Y., Park, Bernard J., Wu, Abraham J., Jones, David R., Molena, Daniela
フォーマット: Artigo
言語:Inglês
出版事項: 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5960990/
https://ncbi.nlm.nih.gov/pubmed/29548582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.01.086
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料